Abstract:Background: FGF21 increases glucose uptake in adipocytes by enhancing the expression of glucose transporter-1 (GLUT1). Results: FGF21 induces the phosphorylation of the transcription factors serum response factor (SRF) and Ets-like protein-1 (Elk-1), which in turn bind to a highly conserved cis-element within the GLUT1 gene promoter for transcriptional activation. Such a stimulatory effect of FGF21 is impaired in adipose tissue of diet-induced obese mice. Conclusion: SRF and Elk-1 act synergistically to mediate FGF21-induced GLUT1 gene expression in adipocytes. Significance: The findings provide new molecular insights into the metabolic actions of FGF21 in its major target tissue. Fibroblast growth factor 21 (FGF21) is a liver-secreted endocrine factor with multiple beneficial effects on obesity-related disorders. It enhances glucose uptake by inducing the expression of glucose transporter-1 (GLUT1) in adipocytes. Here we investigated the signaling pathways that mediate FGF21-induced GLUT1 expression and glucose uptake in vitro and in animals. Quantitative real-time PCR and a luciferase reporter assay showed that FGF21 induced GLUT1 expression through transcriptional activation. The truncation of the GLUT1 promoter from −3145 to −3105 bp, which contains two highly conserved serum response element (SRE) and E-Twenty Six (ETS) binding motif, dramatically decreased FGF21-induced promoter activity of the GLUT1 gene. A chromatin immunoprecipitation assay demonstrated that the transcription factors serum response factor (SRF) and Ets-like protein-1 (Elk-1) were recruited to the GLUT1 promoter upon FGF21 stimulation. The siRNA-mediated knockdown of either SRF or Elk-1 resulted in a marked attenuation in FGF21-induced GLUT1 expression and glucose uptake in adipocytes. In C57 lean mice, a single intravenous injection of FGF21 induced phosphorylation of Elk-1 at Ser383 and SRF at Ser103 and also led to the recruitment of Elk-1 and SRF to the GLUT1 promoter in epididymal fats. By contrast, such effects of in vivo FGF21 administration were blunted in high fat diet-induced obese mice. In conclusion, FGF21 induces GLUT1 expression and glucose uptake through sequential activation of ERK1/2 and SRF/Elk-1, which in turn triggers the transcriptional activation of GLUT1 in adipocytes. The impairment in this signaling pathway may contribute to FGF21 resistance in obese mice.

Fibroblast Growth Factor 21 Reverses Suppression of Adiponectin Expression Via Inhibiting Endoplasmic Reticulum Stress in Adipose Tissue of Obese Mice

Fibroblast Growth Factor 21 Increases Insulin Sensitivity Through Specific Expansion of Subcutaneous Fat

Fibroblast Growth Factor-21 Maintains Glucose Homeostasis Through Influencing the Expansion and Function of Subcutaneous Adipose Tissue

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

Fibroblast Growth Factor 21 is Regulated by the IRE1α-XBP1 Branch of the Unfolded Protein Response and Counteracts Endoplasmic Reticulum Stress-Induced Hepatic Steatosis.

Fibroblast Growth Factor 21 Suppresses Adipogenesis in Pig Intramuscular Fat Cells

Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice

Fibroblast growth factor 21 improves insulin sensitivity by modulating the bile acid-gut microbiota axis in type Ⅱ diabetic mice

Cellular Mechanisms by Which Fgf21 Improves Insulin Sensitivity in Male Mice

Fibroblast Growth Factor 21 Exerts Its Anti‐inflammatory Effects on Multiple Cell Types of Adipose Tissue in Obesity

FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity.

Mechanisms of the Role of Fibroblast Growth Factor 21 in Attenuating Insulin Resistance

Downstream Signaling Pathways in Mouse Adipose Tissues Following Acute in Vivo Administration of Fibroblast Growth Factor 21.

Silencing of FGF‐21 Expression Promotes Hepatic Gluconeogenesis and Glycogenolysis by Regulation of the STAT3–SOCS3 Signal

Fibroblast Growth Factor 21 Induces Glucose Transporter-1 Expression through Activation of the Serum Response Factor/Ets-Like Protein-1 in Adipocytes*

Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway

Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.

Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives

Fibroblast Growth Factor 21 Stimulates Pancreatic Islet Autophagy via Inhibition of AMPK-mTOR Signaling

The molecular mechanism of fibroblast growth factor 21-inhibited leptin expression in adipocytes

FGF21 Normalizes Plasma Glucose in Mouse Models of Type 1 Diabetes and Insulin Receptor Dysfunction